×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
LON:DOCS

Dr. Martens (DOCS) Share Forecast, Price & News

GBX 209.20
+3.00 (+1.45%)
(As of 05/27/2022 12:00 AM ET)
Add
Compare
Today's Range
205.80
210.80
50-Day Range
182.90
249.40
52-Week Range
174.70
517
Volume
530,917 shs
Average Volume
1.74 million shs
Market Capitalization
£2.09 billion
P/E Ratio
38.74
Dividend Yield
1.25%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive DOCS News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

Dr. Martens logo

About Dr. Martens

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Footwear & Accessories
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,897
Year Founded
N/A

Sales & Book Value

Annual Sales
£824.70 million
Cash Flow
GBX 12.07 per share
Book Value
GBX 20.40 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
1,000,111,000
Free Float
N/A
Market Cap
£2.09 billion
Optionable
Not Optionable

Company Calendar

Today
5/28/2022
Next Earnings (Estimated)
6/01/2022

MarketRank

Overall MarketRank

2.03 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Dr. Martens (LON:DOCS) Frequently Asked Questions

Is Dr. Martens a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Dr. Martens stock.
View analyst ratings for Dr. Martens
or view top-rated stocks.

When is Dr. Martens' next earnings date?

Dr. Martens is scheduled to release its next quarterly earnings announcement on Wednesday, June 1st 2022.
View our earnings forecast for Dr. Martens
.

How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens?

Dr. Martens announced a dividend on Thursday, December 9th. Shareholders of record on Thursday, January 13th will be paid a dividend of GBX 1.22 per share on Friday, February 4th. This represents a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, January 13th. The official announcement can be viewed at this link.
View Dr. Martens' dividend history
.

Is Dr. Martens a good dividend stock?

Dr. Martens pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.25%. The dividend payout ratio of Dr. Martens is 37.04%. This payout ratio is at a healthy, sustainable level, below 75%.
View Dr. Martens' dividend history.

What price target have analysts set for DOCS?

3 analysts have issued 1 year price targets for Dr. Martens' shares. Their forecasts range from GBX 360 to GBX 535. On average, they expect Dr. Martens' stock price to reach GBX 423.33 in the next year. This suggests a possible upside of 102.4% from the stock's current price.
View analysts' price targets for Dr. Martens
or view top-rated stocks among Wall Street analysts.

Who are Dr. Martens' key executives?
Dr. Martens' management team includes the following people:
  • Mr. Kenneth Wilson, CEO & Director (Age 55, Pay $815.25k)
  • Mr. Jon W. Mortimore, CFO & Director
  • Mr. Geert Peeters, Chief Operating Officer (Age 56)
  • Mr. Ronald Garricks, Chief Information Officer
  • Ms. Emily Reichwald, Gen. Counsel & Company Sec.
  • Mr. Darren Campbell, Chief Product & Marketing Officer
  • Ms. Sue Gannon, Chief HR Officer
  • Mr. Lorenzo Moretti, Pres of EMEA
  • Mr. Leslie Lane, Pres of Americas Region (Age 54)
  • Mr. Sean O'Neill, Chief Digital Officer
What is Dr. Martens' stock symbol?

Dr. Martens trades on the London Stock Exchange (LON) under the ticker symbol "DOCS."

How do I buy shares of Dr. Martens?

Shares of DOCS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Dr. Martens' stock price today?

One share of DOCS stock can currently be purchased for approximately GBX 209.20.

How much money does Dr. Martens make?

Dr. Martens has a market capitalization of £2.09 billion and generates £824.70 million in revenue each year.

How many employees does Dr. Martens have?

Dr. Martens employs 1,897 workers across the globe.

What is Dr. Martens' official website?

The official website for Dr. Martens is www.drmartensplc.com.

How can I contact Dr. Martens?

The company can be reached via phone at 44 12 1415 7047.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.